Postmenopausal Hormone Therapy and Cardiovascular Risk

Once thought to universally increase heart attack and stroke risk, hormone therapy (HT) is now recommended for women who meet certain criteria

0

Every day, about 6 million women in the United States begin the menopause transition. About 75% will experience hot flashes and night sweats, two vasomotor symptoms (VMS) that can seriously interfere with quality of life.

To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access